LAUSR

As mentioned, acute ischemic stroke (AIS) is one of the deadliest complications of mitral valve thrombi. It has been reported in the literature that combined embolic events are seen at rates ranging from nearly 1.5% to 20% in surgically treated patients and those receiving thrombolytic therapy. In the studies by “Hattusha”2 and “Prometee”3, 2.4% and 1.7% embolic events were observed, respectively, in the groups receiving low-dose ultra-slow thrombolytic therapy. Consistent with the literature, there is no definite information on how to approach embolic events that develop during treatment in these studies. In this step, individualized management is recommended considering both the severity of the complication and the residual valvular obstruction.